Argent Biopharma (AU:RGT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent BioPharma Ltd., a leader in multidisciplinary drug development, has announced its Annual General Meeting scheduled for November 28, 2024. Prospective directors have until October 10, 2024, to submit their nominations. The company specializes in advanced therapies for the central nervous system and immunology.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.